Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol before versus after cesarean section for bleeding reduction
IRCT20180107038254N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Amount of blood loss and Hemoglobin level decline. Started Jan 2018; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20180107038254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180107038254N1.